SCHEMBL30738319

SCHEMBL30738319

Cc1ncnc2ccc(-c3nnc(N)nc3-c3ccc(F)cc3)cc12

nearest known ligand 0.59

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 15/20 0.59
▸ ADORA1 P30542 14/20 0.59
▸ ADORA2B P29275 3/20 0.59
▸ ADORA3 P0DMS8 1/20 0.53
▸ MAP4K4 O95819 3/20 0.49
▸ EGFR P00533 1/20 0.41
▸ USP2 O75604 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ CLK4 Q9HAZ1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20392686 1.00 ADORA2A (0.59) ADORA2AADORA1ADORA2BADORA3MAP4K4
SCHEMBL21569365 0.92 ADORA2A (0.52) ADORA2AADORA1ADORA2BADORA3MAP4K4
SCHEMBL20392542 0.89 ADORA2A (0.56) ADORA2AADORA1ADORA2BMAP4K4
SCHEMBL20392590 0.88 ADORA2A (0.59) ADORA2AADORA1ADORA2BADORA3MAP4K4
SCHEMBL20392695 0.88 ADORA2A (0.44) ADORA2AADORA1ADORA2BADORA3MAP4K4
SCHEMBL20392697 0.85 ADORA2A (0.52) ADORA2AADORA1ADORA2BADORA3MAP4K4
SCHEMBL20392684 0.85 ADORA2A (0.52) ADORA2AADORA1ADORA2BADORA3MAP4K4
SCHEMBL23692313 0.83 ADORA2A (0.52) ADORA2AADORA1ADORA2BADORA3MAP4K4
SCHEMBL20392664 0.83 ADORA2A (0.60) ADORA2AADORA1ADORA2BADORA3
SCHEMBL20392699 0.83 ADORA2A (0.59) ADORA2AADORA1ADORA2BADORA3USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166119-B Substituted aryl compound and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2024-01-05 — — CN disclosed
Send feedback